OrthoPediatrics (KIDS) Misses Q3 EPS by 11c, updates guidance

OrthoPediatrics (NASDAQ: KIDS) reported Q3 EPS of ($0.34), $0.11 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $54.57 million versus the consensus estimate of $53.73 million.

GUIDANCE:

OrthoPediatrics sees FY2024 revenue of $202-204 million, versus the consensus of $201.8 million.

For earnings history and earnings-related data on OrthoPediatrics (KIDS) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• Synchrony partners with OpenAI to integrate AI into shopping